In gliomas, CCL2's production is vital for recruiting immunosuppressive CCR4+ Tregs and CCR2+ Ly‐6C+ monocytic myeloid‐derived suppressor cells [27]. This evidence concerns the gene CCR2 and central nervous system cancer.